Björck, Lars

Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients

Lorant, T., Bengtsson, M., Eich, T., Eriksson, B.-M., Winstedt, L., Järnum, S., Stenberg, Y., Robertson, A.-K., Mosén, K., Björck, L., et al. (2018) · American Journal of Transplantation

Renal Transplantation Outcomes and TreatmentsMonoclonal and Polyclonal Antibodies Research

Cited by 108

Bacterial Surface Protein L Binds and Inactivates Neutrophil Proteins S100A8/A9

Åkerström, B., & Björck, L. (2009) · The Journal of Immunology

S100 Proteins and AnnexinsBiochemical and Structural Characterization

Cited by 23